Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Appointed CFO
Quarterly results
Inv. presentation
Director departure
|
|
NovaBay Pharmaceuticals, Inc. (NBY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/05/2022 |
4/A
| Kunin Audrey (Chief Product Officer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 5,960 shares
@ $2.1049, valued at
$12.5k
|
|
| 12/05/2022 |
4/A
| Kunin Jeffrey (President, DERMAdoctor, LLC) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Sold 5,960 shares
@ $2.1049, valued at
$12.5k
|
|
| 10/28/2019 |
4/A
| Raleigh Jason Philip (Interim CFO and Treasurer) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 23,405 shares
@ $2.2, valued at
$51.5k
Sold 23,405 shares
@ $3, valued at
$70.2k
Granted 9,750 shares
@ $2.35, valued at
$22.9k
Sold 9,750 shares
@ $3.75, valued at
$36.6k
Exercised (in-or-at-the-money) 23,405 options to buy
@ $2.2, valued at
$51.5k
Exercised (in-or-at-the-money) 9,750 options to buy
@ $2.35, valued at
$22.9k
|
|
| 10/28/2019 |
4/A
| Hall Justin (Interim President & CEO and GC) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 47,500 shares
@ $2.02, valued at
$96k
Sold 47,500 shares
@ $3.03, valued at
$143.9k
Exercised (in-or-at-the-money) 47,500 options to buy
@ $2.02, valued at
$96k
|
|
| 01/19/2018 |
4/A
| Ma Yonghao (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 20,326 options to buy
@ $3.24, valued at
$65.9k
|
|
| 10/04/2016 |
4/A
| Zavodnick Todd Erik (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 247 options to buy
@ $3.99, valued at
$985.5 |
|
| 11/01/2012 |
4/A
| Najafi Ramin (CEO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/01/2012 |
4/A
| Khosrovi Behzad (SVP Product Development) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/01/2012 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
| 11/01/2012 |
4/A
| Stroman David W. (SVP, Ophthalmic Product Devt.) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/01/2012 |
4/A
| PAULSON THOMAS J (CFO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 02/01/2011 |
4/A
| Khosrovi Behzad (SVP Product Development & CAO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 35,400 options to buy
@ $1.95, valued at
$69k
|
|
| 02/01/2011 |
4/A
| O'Reilly John James (SVP Business and Corporate Dev) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 44,400 options to buy
@ $1.95, valued at
$86.6k
|
|
| 02/01/2011 |
4/A
| PAULSON THOMAS J (CFO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 02/01/2011 |
4/A
| Scott Colin (VP, Clinical Research and Dev) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 02/01/2011 |
4/A
| Najafi Ramin (CEO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 01/27/2011 |
4/A
| Cashion Charles (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 01/27/2011 |
4/A
| McPherson T. Alex (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 01/18/2011 |
4/A
| Wicks Tony D.S. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 01/18/2011 |
4/A
| Tufts Robert R. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 01/18/2011 |
4/A
| Freiman Paul E. (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 01/18/2011 |
4/A
| Dailley Anthony (Director) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 12/22/2010 |
4/A
| WU ROY J (SVP Bus & Corp Development) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 12/22/2010 |
4/A
| Khosrovi Behzad (SVP Product Development & CAO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 12/22/2010 |
4/A
| PAULSON THOMAS J (CFO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 12/22/2010 |
4/A
| Najafi Ramin (CEO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 12/22/2010 |
4/A
| Anderson Mark Brian (CSO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/17/2010 |
4/A
| WU ROY J (SVP Bus & Corp Development) has filed a Form 4 on NovaBay Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 11/17/2010 |
4/A
| Khosrovi Behzad (SVP Product Development & CAO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/17/2010 |
4/A
| PAULSON THOMAS J (CFO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/17/2010 |
4/A
| Najafi Ramin (CEO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/17/2010 |
4/A
| Anderson Mark Brian (CSO) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/15/2010 |
4/A
| Khosrovi Behzad (VP Research and Development) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
| 11/15/2010 |
4/A
| Khosrovi Behzad (VP Research and Development) has filed a Form 4 on NovaBay Pharmaceuticals, Inc. |
|
|
|